Single dose pharmacokinetics of syrup of ipecac

Therapeutic Drug Monitoring

Volumn 22, Issue 5, 2000, Pages 566-573

  Scharman, Elizabeth J ^a,b   Hutzler, J Matthew ^b   Rosencrance, J Gregory ^c   Tracy, Timothy S ^b  

^a West Virginia Poison Center   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c West Virginia University School of Medicine Charleston   (United States)

Author keywords

Cephaeline; Emetine; Forensic; HPCL; Ipecac; Muncha usen's; Pharmacokinetics; Poisoning; Toxicity; Toxicology

Indexed keywords

ALKALOID; CEPHAELINE; EMETINE; IPECAC;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ELIMINATION; DRUG INTOXICATION; DRUG MONITORING; DRUG URINE LEVEL; FEMALE; FLUORESCENCE ANALYSIS; HUMAN; MALE; MUNCHAUSEN SYNDROME; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TOXICITY TESTING;

ADOLESCENT; ADULT; AREA UNDER CURVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; EMETICS; EMETINE; FEMALE; HUMANS; IPECAC; MALE; MIDDLE AGED;

EID: 0033797534     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200010000-00011     Document Type: Article

References (37)

1. The pharmacology of emetin
2. Toxicology of ipecac: A review
3. Evaluation of gastric emptying using radionuclides: Gastric lavage versus ipecac-induced emesis
4. 1994 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System
5. Emetine identified in urine by HPLC, with fluorescence and ultraviolet/diode array detection, in a patient with cardiomyopathy
6. Intentional ipecac poisoning in children
7. Surreptitious ipecac administration simulating intestinal pseudo-obstruction
8. Studies on the toxicity, distribution and excretion of emetine
9. Absorption of ipecac alkaloids in emergency patients
10. Sudden onset of profound weakness in a toddler
11. Clinical and toxicological findings in two young siblings and autopsy findings in one sibling with multiple hospital admissions resulting in death
12. Ipecac myopathy and cardiomyopathy
13. Myopathy due to ipecac syrup poisoning in a patient with anorexia nervosa
14. Reversible myopathy secondary to abuse of ipecac in patients with major eating disorders
15. Emetine myopathy in a patient with an eating disorder
16. Reversible emetine-induced myopathy with ECG abnormalities: A toxic myopathy
17. Rapidly reversible cardiomyopathy associated with chronic ipecac ingestion
18. Intentional ipecac poisoning: Munchausen Syndrome by proxy
19. Hemorrhagic colitis and pseudomelanosis coli in ipecac ingestion by proxy
20. Chronic ipecac poisoning in infancy: A case report
21. Ipecac toxicity in 'Munchausen syndrome by proxy'
22. Secretory diarrhea caused by ipecac poisoning
23. Cardiomyopathy from ipecac administration in Munchausen syndrome by proxy
24. Recurrent infantile vomiting due to intentional ipecac poisoning
25. Pediatrics
26. Death resulting from ipecac
27. Quantitative analysis of emetine and cephaeline by reversed-phase high performance liquid chromatography with fluorescence detection
28. Ipecac-induced emesis versus gastric lavage: A controlled study in normal adults
29. Efficacy of charcoal cathartic versus ipecac in reducing serum acetaminophen in a simulated overdose
30. Pediatric gastrointestinal decontamination in acute toxin ingestion
31. Position statement: Ipecac syrup
32. The United States Pharmacopiea, 21st ed Rockville MD: United States Pharmacopeial Convention
33. Determination of the potency of outdated ipecac using high pressure liquid chromatography and its clinical significance
34. Some aspects of the metabolism of 14C-labeled 2,3-dehydroemetine in the rat